Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabran J Masoud

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 18, 2020
Improved overall survival is still observed in patients receiving delayed adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic adenocarcinomaMegan C Turner, Sabran J Masoud, Marcelo Cerullo, et al.
Annals of Surgical Oncology|July 26, 2024
Market Factors, Not Quality, Influence Reimbursement for Pancreaticoduodenectomy in an Era of Price TransparencySabran J Masoud, Anthony T Saxton, Michael E Lidsky, et al.
Annals of Surgical Oncology|September 2, 2025
Social Vulnerability as a Neighborhood-Level Determinant of Pancreatic Cancer Survivorship: A National Analysis of Veterans Affairs PatientsSabran J Masoud, Alex J Bartholomew, Michael E Lidsky, et al.
Journal of Surgical Oncology|September 6, 2023
Tumor size and survival in intrahepatic cholangiocarcinoma treated with surgical resection or ablationElishama N Kanu, Kristen E Rhodin, Sabran J Masoud, et al.
Annals of Surgical Oncology|July 12, 2023
Comparing Survival After Resection, Ablation, and Radiation in Small Intrahepatic CholangiocarcinomaSabran J Masoud, Kristen E Rhodin, Elishama Kanu, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 18, 2020
Improved overall survival is still observed in patients receiving delayed adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic adenocarcinomaMegan C Turner, Sabran J Masoud, Marcelo Cerullo, et al.
Annals of Surgical Oncology|July 26, 2024
Market Factors, Not Quality, Influence Reimbursement for Pancreaticoduodenectomy in an Era of Price TransparencySabran J Masoud, Anthony T Saxton, Michael E Lidsky, et al.
Annals of Surgical Oncology|September 2, 2025
Social Vulnerability as a Neighborhood-Level Determinant of Pancreatic Cancer Survivorship: A National Analysis of Veterans Affairs PatientsSabran J Masoud, Alex J Bartholomew, Michael E Lidsky, et al.
Journal of Surgical Oncology|September 6, 2023
Tumor size and survival in intrahepatic cholangiocarcinoma treated with surgical resection or ablationElishama N Kanu, Kristen E Rhodin, Sabran J Masoud, et al.
Annals of Surgical Oncology|July 12, 2023
Comparing Survival After Resection, Ablation, and Radiation in Small Intrahepatic CholangiocarcinomaSabran J Masoud, Kristen E Rhodin, Elishama Kanu, et al.
Pageof 2